Is Amazon an AI Stock?
With the market starting to look skittish on pure-play AI…
Sell
39
MURA Quote, Financials, Valuation and Earnings
Last price:
$2.04
Seasonality move
:
19.71%
Day range:
$2.03 - $2.04
52-week range:
$0.95 - $4.74
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
0.64x
Volume:
127.8K
Avg. volume:
202.3K
1-year change:
-49.13%
Market cap:
$35.4M
Revenue:
--
EPS (TTM):
-$6.93
Analysts' Opinion
-
Consensus RatingMural Oncology Plc has received a consensus rating of Hold. The company's average rating is a Hold based on 0 Buy ratings, 1 Hold rating, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $5.00, Mural Oncology Plc has an estimated upside of 194.12% from its current price of $2.04.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $4.00 representing 100% downside risk from its current price of $2.04.
Fair Value
-
According to the consensus of 1 analyst, Mural Oncology Plc has 194.12% upside to fair value with a price target of $5.00 per share.
MURA vs. S&P 500
-
Over the past 5 trading days, Mural Oncology Plc has overperformed the S&P 500 by 0.87% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
Mural Oncology Plc does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Mural Oncology Plc has grown year-over-year revenues for 0 quarters straight. In the most recent quarter Mural Oncology Plc reported revenues of --.
Earnings Growth
-
Mural Oncology Plc has grown year-over-year earnings for 1 quarter straight. In the most recent quarter Mural Oncology Plc reported earnings per share of -$0.21.
Enterprise value:
-21.7M
EV / Invested capital:
-0.37x
Price / LTM sales:
--
EV / EBIT:
--
EV / Revenue:
--
PEG ratio (5yr expected):
-0.01x
EV / Free cash flow:
0.18x
Price / Operating cash flow:
--
Enterprise value / EBITDA:
--
Gross Profit (TTM):
-$3.6M
Return On Assets:
-90.49%
Net Income Margin (TTM):
--
Return On Equity:
-111%
Return On Invested Capital:
-104.55%
Operating Margin:
--
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Income Statement | ||||||
| Revenue | -- | -- | -- | -- | -- | |
| Gross Profit | -$2.2M | -$3.3M | -$3.6M | -$899K | -$800K | |
| Operating Income | -$185.5M | -$160.9M | -$105.6M | -$34.1M | -$4M | |
| EBITDA | -$183.4M | -$157.7M | -$101.9M | -$33.2M | -$3.2M | |
| Diluted EPS | -$11.80 | -$9.14 | -$6.93 | -$1.87 | -$0.21 | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | -- | -- | $5M | $183.8M | $62.2M | |
| Total Assets | -- | -- | $30.2M | $203.3M | $65.8M | |
| Current Liabilities | -- | -- | $26.4M | $24.9M | $10.5M | |
| Total Liabilities | -- | -- | $37.1M | $29.1M | $10.6M | |
| Total Equity | -- | -- | -$6.9M | $174.1M | $55.2M | |
| Total Debt | -- | -- | $10.5M | $4.1M | $42K | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | -- | -$139.5M | -$118.4M | -$30.1M | -$18.5M | |
| Cash From Investing | -- | -$62.7M | $66M | $19.3M | -- | |
| Cash From Financing | -- | $315.2M | $28K | $196K | -- | |
| Free Cash Flow | -- | -$140.7M | -$118.5M | -$30.1M | -$18.5M | |
MURA
Sector
Market Cap
$35.4M
$28.4M
Price % of 52-Week High
43.04%
50.35%
Dividend Yield
0%
0%
Shareholder Yield
4.12%
-1.32%
1-Year Price Total Return
-49.13%
-22.19%
Beta (5-Year)
--
0.521
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
Technicals
8-day SMA
Sell
Level
$2.05
200-day SMA
Sell
Level
$2.37
Bollinger Bands (100)
Sell
Level
1.9 - 2.26
Chaikin Money Flow
Sell
Level
-170M
20-day SMA
Sell
Level
$2.07
Relative Strength Index (RSI14)
Sell
Level
40.09
ADX Line
Sell
Level
28.14
Williams %R
Neutral
Level
-75
50-day SMA
Sell
Level
$2.08
MACD (12, 26)
Sell
Level
-0.01
25-day Aroon Oscillator
Sell
Level
-76
On Balance Volume
Neutral
Level
279.7M
Financial Scores
Sell
Altman Z-Score
(Annual)
Level (-1.9719)
Sell
CA Score
(Annual)
Level (-1.4673)
--
Beneish M-Score
(Annual)
Level (--)
Sell
Momentum Score
Level (2)
Sell
Ohlson Score
Level (7.875)
--
Piotroski F Score
(Annual)
Level (--)
Sell
Quality Ratio Score
Level (1)
Sell
Fundamental Score
Level (2)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Mural Oncology Plc is a clinical-stage oncology company, which focuses on discovering and developing immunotherapies that may meaningfully improve the lives of patients with cancer. Its lead product candidate is the Nemvaleukin Alfa which is an interleukin-2 cytokine designed to capture and expand therapeutic benefits of high-dose recombinant human IL-2. The company was founded on May 31, 2017 and is headquartered in Dublin, Ireland.
Stock Forecast FAQ
In the current month, MURA has received 0 Buy ratings 1 Hold ratings, and 0 Sell ratings. The MURA average analyst price target in the past 3 months is $5.00.
-
Where Will Mural Oncology Plc Stock Be In 1 Year?
According to analysts, the consensus estimate is that Mural Oncology Plc share price will rise to $5.00 per share over the next 12 months.
-
What Do Analysts Say About Mural Oncology Plc?
Analysts are divided on their view about Mural Oncology Plc share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Mural Oncology Plc is a Sell and believe this share price will drop from its current level to $4.00.
-
What Is Mural Oncology Plc's Price Target?
The price target for Mural Oncology Plc over the next 1-year time period is forecast to be $5.00 according to 1 Wall Street analyst, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 1 analyst rates the stock a Hold.
-
Is MURA A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Mural Oncology Plc is a Hold. 1 of 1 analysts rates the stock a Hold at this time.
-
How Can I Buy Shares Of MURA?
You can purchase shares of Mural Oncology Plc via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Mural Oncology Plc shares.
-
What Is The Mural Oncology Plc Share Price Today?
Mural Oncology Plc was last trading at $2.04 per share. This represents the most recent stock quote for Mural Oncology Plc. Yesterday, Mural Oncology Plc closed at $2.04 per share.
-
How To Buy Mural Oncology Plc Stock Online?
In order to purchase Mural Oncology Plc stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Get MURA Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
MURA
Sector
P/E ratio
--
23.66x
PEG ratio
-0.01x
-0.01x
P/B ratio
0.64x
1.84x
Price / LTM sales
--
1.60x
Growth Metrics
MURA
Sector
Revenue growth
--
4.85%
Earnings growth
88.53%
11.15%
Revenue (5-year growth)
--
6.45%
Earnings forecast
-$0.59
-$0.20
Profitability
MURA
Sector
Profitability FY 2024
-$3.5M
$3.6M
Return on invested capital
-104.55%
-30.98%
Return on assets
-90.49%
-27.62%
Return on equity
-111%
-36.69%
Earnings Date
Last Earnings Date
Dec
5
Next Earnings Date
Dec
5
Estimated Next Earnings Date
Mar
6
Balance Sheet
MURA
Sector
Total cash
$60.6M
$27.2M
Short term investments
$28.9M
$25.7M
Total assets
$169.4M
$79.9M
Long term debt
$42K
$4.1M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Google Vs NVIDIA Stock: Which Is Best?
Alphabet (NASDAQ:GOOGL) and NVIDIA (NASDAQ:NVIDIA) are two of the market’s…
How High Could NVIDIA Stock Go?
NVIDIA (NASDAQ:NVDA) has been one of the best stocks to…
Stock Ideas
Buy
52
Is NVDA Stock a Buy?
Market Cap: $4.5T
P/E Ratio: 62x
Buy
61
Is AAPL Stock a Buy?
Market Cap: $4.1T
P/E Ratio: 38x
Buy
63
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 40x
Alerts
Buy
54
SMX alert for Dec 5
SMX (Security Matters) Plc [SMX] is up 154.74% over the past day.
Sell
15
HOV alert for Dec 5
Hovnanian Enterprises, Inc. [HOV] is down 22.58% over the past day.
Buy
67
NUTX alert for Dec 5
Nutex Health, Inc. [NUTX] is up 18.9% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
